Minda buys GSK 54.5: Glaxo (GSK), Theravance (THRX) Issue Positive Update on Ellipta Phase IIIs in COPD
GlaxoSmithKline plc (NYSE: GSK) and Theravance, Inc. (Nasdaq: THRX) announced positive results from two phase III studies, which showed that patients with chronic obstructive pulmonary disease (COPD) who received the anticholinergic, Incruse" Ellipta ... ...
34 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home